Clinical Trial

Efficacy and Safety of Oral Midazolam Used for the Delivery of Care in Elderly Patient With Neurocognitive Disorders and Refusing Care.

Study acronym: MIRAGE
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated December 15, 2025 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to assess the effectiveness of oral midazolam on the delivery of care in elderly patients with moderat to severe neurocognitive disorders and opposing care.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-10-10; most recent amendment 2025-12-05.
Status change: Not Yet Recruiting → Recruiting 2025-12-05
Trial Details
NCT Number NCT06638710
Lead Sponsor University Hospital, Grenoble
Conditions Neurocognitive Disorders
Enrollment 30 participants
Start Date 2025-07-08
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-15